Capmatinib in patients with MET-positive advanced non-small cell lung cancer: analysis of the Russian cohort in the Geometry mono-1 study. (2022). Voprosy Onkologii, 68(6), 758-767. https://doi.org/10.37469/0507-3758-2022-68-6-758-767